Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up Meeting Abstract
| Authors: | McDermott, R. S.; van Tilburg, C.; Lin, J. J.; Kummar, S.; Tan, D. S. W.; Albert, C. M.; Berlin, J. D.; Lassen, U. N.; Doz, F.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Norenberg, R.; Dima, L.; Mussi, C.; De La Cuesta, E. A.; Laetsch, T.; Hong, D. S.; Drilon, A. E. |
| Abstract Title: | Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S751 |
| End Page: | S752 |
| Language: | English |
| ACCESSION: | WOS:000866211600457 |
| DOI: | 10.1016/j.annonc.2022.07.592 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 463P -- Source: Wos |
